Bliss Gvs Pharma Q4 Results

  • BSE: 506197
  • NSE: BLISSGVS
  • ISIN: INE416D01022
  • Sector: Biotechnology & Drugs
BSE
132.250.75 (0.57%)
Volume36.39 K
Updated: Mon 25 Nov, 2024 | 15:28:00
NSE
132.420.87 (0.66%)
Volume8.33 L
Updated: Mon 25 Nov, 2024 | 15:44:17
Today: 132.10
138.20
52-Wk: 92.25
148.95

Q4 Results Highlights

    Note: Comparison is on QoQ basis

    Quarterly - Bliss Gvs Pharma Q4 Results

    *All figures in crores except per share values
    Fiscal PeriodMar 24Dec 22QoQ CompMar 23YoY Comp
    Total Revenue 198.13205.72-%184.78-%
    Selling/ General/ Admin Expenses Total 24.5122.14-%22.51-%
    Depreciation/ Amortization 6.854.64-%4.88-%
    Other Operating Expenses Total 49.8034.50-%47.05-%
    Total Operating Expense 205.82162.67-%183.42-%
    Operating Income -7.7043.05-%1.36-%
    Net Income Before Taxes -3.9547.43-%-0.75-%
    Net Income -9.1527.94-%3.34-%
    Diluted Normalized EPS 0.952.64-%0.32-%

    Recommended For You

      More Recommendations

      Trending Stocks

        Subscribe to Our Newsletter

        Get daily newsletters around different themes from livemint.

        Subscribe
        HomeMarketsPremiumInstant LoanMint Shorts